F1 hybrid mice are able to acutely reject parental marrow grafts, a phenomenon that is due to natural killer type 1-positive (NKI+) cells. Circumstantial evidence had suggested that the antigenic determinants recognized by these cells are self-antigens, leading to the hypothesis that the physiological role of NK1 + cells is a downregulatory or suppressive function on bone marrow stem cell proliferation and lymphocyte function. In analyzing this hypothesis it is shown here that in young mice there is a temporal correlation between appearance of NK1 + cells in the spleen and the ability to reject allogeneic marrow or to suppress endogenous stem cell proliferation. The reverse situation exists in mice expressing the homozygous Ipr gene. Whereas in young mice cells with NK1 + phenotype are demonstrable, these cells disappear with age, i.e., at the time autoimmunity develops. Concomitant with the disappearance of NK1 + cells, the ability to reject marrow grafts and to control endogenous stem cell proliferation also vanishes. The suggestion that the development of autoimmunity is causally related to the disappearance of NK1 + cells is supported by experiments in which NK1 + cells were either eliminated by antibody injection or increased by adoptively transferring cell populations enriched for NK1 + cells into Ipr mice. It is shown that removal of cells enhances autoimmunity, whereas injection of NK1 + cells delays the onset of autoimmunity. In vitro assays are presented that demonstrate that suppression of autoantibody-secreting B cells is due to two NK1 § cell populations, one that expresses CD3 and causes specific suppression and one that lacks CD3 and causes nonspecific suppression.
F1 hybrid mice are able to acutely reject parental marrow grafts, a phenomenon that is due to natural killer type 1-positive (NKI+) cells. Circumstantial evidence had suggested that the antigenic determinants recognized by these cells are self-antigens, leading to the hypothesis that the physiological role of NK1 + cells is a downregulatory or suppressive function on bone marrow stem cell proliferation and lymphocyte function. In analyzing this hypothesis it is shown here that in young mice there is a temporal correlation between appearance of NK1 + cells in the spleen and the ability to reject allogeneic marrow or to suppress endogenous stem cell proliferation. The reverse situation exists in mice expressing the homozygous Ipr gene. Whereas in young mice cells with NK1 + phenotype are demonstrable, these cells disappear with age, i.e., at the time autoimmunity develops. Concomitant with the disappearance of NK1 + cells, the ability to reject marrow grafts and to control endogenous stem cell proliferation also vanishes. The suggestion that the development of autoimmunity is causally related to the disappearance of NK1 + cells is supported by experiments in which NK1 + cells were either eliminated by antibody injection or increased by adoptively transferring cell populations enriched for NK1 + cells into Ipr mice. It is shown that removal of cells enhances autoimmunity, whereas injection of NK1 + cells delays the onset of autoimmunity. In vitro assays are presented that demonstrate that suppression of autoantibody-secreting B cells is due to two NK1 § cell populations, one that expresses CD3 and causes specific suppression and one that lacks CD3 and causes nonspecific suppression.
"][ thally irradiated mice have the ability to acutely reject certain allogeneic and MHC-matched bone marrow grafts. In normal and thymus-deficient nude mice, the principal cell type responsible for the rejection is a cell that expresses cell surface markers characteristic for NK cells as well as the CD3 TCR complex (1-3), whereas in SCID mice cells with a similar phenotype but lacking TCRs perform this function (4) . The observation that effector cells with NK phenotype cause the rejection of MHC-matched marrow transplants raises the possibility that the responsible cells recognize selfantigens. In support of this, it had been shown that cells with NK phenotype may cause suppression of endogenous marrow stem cell proliferation (5) . This led to the hypothesis that the physiological role of these cells is to control marrow stem cell proliferation. To examine this hypothesis, we sought to correlate the presence of cells with NK phenotype with the ability of mice to suppress stem cell proliferation. Here we report that in young mice the appearance of NK1 + cells correlates with the ability to downregulate stern cell proliferation, whereas in aging mice with the homozygous lpr gene, NK1 + cells disappear concomitant with the loss of ability to limit stem call proliferation. Previous observations reported by Scribner and Steinberg (6) had shown that the ability of mice expressing the Ipr or gld mutations to limit the number of endogenous CPU-spleen (S) 1 declines with age. This suggested that the development of autoimmunity and ability to limit endogenous stem cell proliferation are causally related. We therefore set out to explore whether there is a correla-tion between the disappearance of cells responsible for acute marrow graft rejection and development of autoimmunity. Here we show that this correlation exists and that in vivo ablation of NK1 § cells leads to an earlier devdopment of autoimmunity. In contrast, adoptive transfer of cell populations enriched for NK1 + cells into Ipr mice delays the onset of autoimmunity. It is therefore suggested that the physiological role of NK1 + cells is to control both hemopoietic stem cell proliferation and B cell function.
Materials and Methods
Animals and ln Vivo Procedures. Female C57BL/6, C3H/OuJ, (C57BL/6 x C3H)F1 mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Breeding pairs of C57BL/6 lpr and C3H gld mice purchased from The Jackson Laboratory were bred in our institute. C57BL/6 nu mice were purchased from either The Jackson Laboratory or Taconic Farms, Inc. (Germantown, NY).
For assay of bone marrow graft rejection, bone marrow cells were collected by flushing femur and tibia. Marrow transplantation was done by intravenous injection of bone marrow cells into recipient mice that had received total body "y irradiation of 850 tad. Success of grafting was assayed on day 8 posttransplantation by counting the number of stem cell colonies in the recipient spleen (CFU-S) after fixation in Bouin's solution (1) . Data are shown as scatter graph of individual mice (Fig. 3) or as mean of CFU-S per spleen of groups of three to five mice. To determine the number of endogenous CFU-S, mice received a dose of 500 tad 3, irradiation 8 d before examination for CFU-S (7, 8) . Data shown represent mean + SD of CFU-S per spleen of groups of three to five mice (5) . To deplete NK1 § cells, 1-wk-old mice were injected intraperitoneally weekly with an increasing dose of mouse mAb PK136 (anti-NKl.1) ascites according to a previously described protocol (9) .
Cell Separations, Antibody Treatment, and Cell Cultures. B cells were removed from spleen cell suspensions by adherence on antiIg-coated plates (10) . Tissue culture-grade polystyrene phtes (Falcon Labware, Oxnard, CA) were coated with 15/~g/ml a~nity-purified goat anti-mouse IgG + IgM (Caltag Laboratories, San Francisco, CA) in PBS. The plate was incubated overnight at 4~ and then washed five times with PBS before use. A single cell suspension of spleen cells was suspended in balanced salt solution (BSS) containing 10% FCS, and 5 x 107 cells were panned on a 150-mm dish in 15 ml of media. Cells were allowed to settle for 1 h at room temperature. Halfway through the incubation the nonadherent cells were resuspended by gently agitating the plate for 30 s. After incubation nonadherent cells were collected by gently agitating the plate and washing it three times with BSS.
For antibody treatment, cells (2 x 107/ml) were incubated for 45 min at 4~ with the respective antibody at optimal concentration, followed by incubation with low toxicity rabbit serum (LowTox M; Cedarlane Laboratories, Hornby, Ontario, Canada) as a source of C for 45 rain at 37~ Optimal concentrations for each antibody were determined by treating nylon wool-nonadherent cells with various dilutions of antibody and C, followed by flow cytometric analysis to assay the success of the treatment. The mAbs T24/31.7 (anti-Thy-1 [11] ), PK136 (anti-YK1 [12] ), 500-A-2 (anti-CD3 [13] ), GK1.5 (anti-CD4 [14] ), and AD4 (15) (anti-CD8 [15] ) were prepared from bybridomas grown in our laboratory.
Cell cultures were set up in RPM11640 supplemented with 10% FCS, 5 x 10 -s M B2-mercaptoethanol, 0.2 mM glutamine, 1 mM Na-pyruvate, and 0.1 mM nonessential amino acids, rlL-2 was obtained from Cetus Corp. (Emeryville, CA). To stimulate expression of NK1 and CD3 antigens, spleen cells depleted of B cells by panning and of CD4, as well as CD8 cells by antibody plus C treatment, were cultured in the presence of Ib2 for the times indicated. Spleen cells from autoimmune mice were cultured for 2 d in the presence of 4/zg/ml LPS to stimulate antibody secretion before enzyme-linked immunospot assay (ELISPOT).
Immunofluorescence Staining and ELISPO'E Indirect double-color immunofluorescence staining was analyzed on a single-laser FACStar Plus | (Becton Dickinson & Co., Mountain View, CA). Rat antibody RA3-3A1/6.1 (anti-B220 [16] ) was obtained from American Type Culture Collection (Rockville, MD). Biotin-labehd goat anti-hamster IgG antibody (Caltag Laboratories), FITC-conjugated affinity-purified F(ab')2 fragment of rabbit anti-mouse IgG Fc, and biotin-conjugated a~nity-purified F(ab')2 fragment of goat anti-rat IgM (Jackson Immunoresearch, Avondale, PA) were used as second antibodies. PE-conjugated streptavidin was purchased from Tago Corp. (Burlingame, CA). Antibodies were used at optimal concentrations for staining (8) . Gates in double staining experiments were set with second antibody controls.
DNA-coated plates were prepared by precoating 96-well flatbottomed tissue culture polystyrene plates (Falcon 3070; Becton Dickinson & Co.) with 0.02% methylated BSA in carbonate buffer. Plates were incubated overnight at 4~ and 100/zl of small pieces of native DNA (Sn DNA) and denatured DNA (dDNA) (100 /~g/ml) in 0.14 M Tris-buffer saline (TBS), pH 7.4, were added then incubated overnight at 4~ Both types of DNA were prepared following described methods (17) . For Ig ELISPOTs, plates were coated with 100/~1 goat anti-mouse IgG + IgM (Caltag Laboratories) (10/zg/ml) in PBS then incubated overnight at 4~ Plates were washed and blocked by incubation with 3% BSA/PBS (100/~l/well) for 3 h at 37~ Plates were washed three times with 100 #1 BSS and incubated with 0.2-1 x 10 s cells per well in 100 /~13% FCS DME at 37~ for 4 h. Plates were washed extensively to remove all cells before adding anti-mouse IgG + IgM biotinconjugated antibodies (Southern Biotechnology Associates) at 100 #l/well in 3% BSA/PBS/0.05% Tween 20. After incubation overnight at 4~ plates were washed, and streptavidin alkaline phosphatase (Southern Biotechnology Associates), 1:1000, 100 #l/well in 3% BSA/PBS/Tween 20, was added followed by incubation for 2 h at 37~ Plates were washed, and 100/~l/well bromochloroindolyl phosphate (BCIP; Sigma Chemical Co., St. Louis, MO) was added in substrate buffer, 0.5% agarose (kept at 55"C to prevent solidification). Plates were incubated for 3 h at 37~ (17) (18) (19) .
Results

In Young Mice the Abilities to Reject Marrow Grafts and to Downregulate Endogenous CFU.S Develop Concositandy with
Appearance of NK1 § Cells. It is well documented that young mice up to the age of 3 wk lack the ability to acutely reject marrow grafts (20) . In agreement with this, it is seen in Fig. I that BCF1 mice transplanted with BALB/c marrow fail to reject grafts up to the age of 23 d. Thereafter resistance develops gradually so that by day 32 complete ability to reject marrow is demonstrable. To examine whether manifestation of resistance correlates with appearance of NK1 + cells, B as well as T call-depleted spleen cells from BCF1 mice were cultured in ID2-containlng medium to stimu- . It therefore appears that cells expressing NK1 or NK1 and CD3 are demonstrable in the spleen of young mice at the time alloresistance to marrow grafts develops, whereas these cells are not present in younger mice not expressing resistance. We had previously provided evidence for a physiological function of NK1 + cells in the suppression of endogenous CFU-S proliferation (5) . If NK1 + cells indeed have this function, one would predict that the ability of young mice to reject allogeneic marrow should correlate with the ability to control the proliferation of endogenous CFU-S. To examine this, mice of various ages were irradiated with 560 tad then assayed for endogenous CFU-S. Fig. 1 shows that 10-d-old mice have very high numbers of CFU-S but that with increasing age the number of CFU-S decreases so that at the age of 22 d values common to adult mice are reached. This shows that in young mice the appearance of NK1 + cells correlates not only with the ability to reject allogeneic marrow grafts but also with the ability to suppress endogenous marrow stem cell proliferation. lack the ability to suppress endogenous stem cell proliferation (6). Therefore, if indeed NK1 + cells are responsible for regulation of stem cell proliferation, one would predict that in lpr mice the ability to suppress endogenous CFU-S disappears concomitantly with ability to reject allogeneic marrow grafts. To examine this prediction, C57BL/6 Ipr mice of varying ages were assayed for B cells secreting autoantibody to monitor the development of autoimmunity. Litter mates were irradiated and assayed for endogenous CFU-S. Table 1 shows that 7-wk-old normal mice possess only a low number of anti-DNA antibody-secreting B cells in their spleens. This is in contrast to C57BL/6 lpr mice of this age, which contain significantly higher number of cells that secrete anti-DNA antibody. Moreover, this number increases dramatically be- * B220 CD3 cells were enriched from 8-mo-old C57BL/6 lpr spleen by B cell panning followed by treatment with anti-CD4 and anti-CD8 + C. Cells were injected 1 d before marrow transplanation into 8-wk-old recipients.
In C57BL/6 Ipr
correlates with loss of ability to control endogenous stem cell proliferation as well as ability to reject allogeneic marrow.
In (Fig. 4 A) and Ipr (Fig. 4 C) mice aged 7 wk is essentially the same and that a significant proportion of cells express either NK1 or NK1 and CD3.
Quite in contrast, the cell population from 9-mo-old Ipr (Fig.   4 D) but not normal mice (Fig. 4 B) Table 2 ) that mice that had received one spleen equivalent of CD3 + B220 + cells and then were transplanted with either syngeneic or allogeneic bone marrow reject the allogeneic but not the syngeneic graft. This demonstrates that B220 + " Culture conditions and enrichment of NK1 + cells were identical to those in Table 3. CD3 § cells have no effect on the ability to reject marrow grafts, consistent with the interpretation that B220 + CD3 + cells do not interfere with the function of cells responsible for acute marrow graft rejection. Table 3 shows that cells from normal C57BL/6 mice suppress Ig secretion of C57BL/6 Ipr B cells 31-37%, and a very similar suppression is seen when cells from 7-wk-old lpr mice were tested (28-36%). In contrast, cells from 9-mo-old Ipr mice have very little suppressive effect Table 3 . Cell populations containing NK1 + cells were treated before culture with anti-CD3 or anti-NK1 + C as indicated. A mixture of cells treated with either anti-CD3 + C or anti-NK1 + C was also assayed for its effects on B cells. (5-6%), consistent with the observation that old Ipr mice lack NK1 + cells. We had previously shown that nude mice possess in their spleens a very high number and activity of cells responsible for acute marrow graft rejection (3). It was therefore interesting to assay the effects of cell populations from these mice. Table 3 shows that cells from C57BL/6 nude mice cause by far the strongest inhibition (61-65%).
NK1 + Cells Are Able to Cause Specific as Well as Nonspecific Suppression of B Cell Ig Secretion In
Next the effects of spleen cell populations from BCF1 enriched for NK1 + cells were tested. BCF1 mice reject parental C57BL/6 but not C3H marrow (1), therefore, NK1 + cells from these mice should suppress B cells from C57BL/6 but not from C3H. To test this, NK1 + cells enriched from BCF1 spleen by depletion of B and T cells were mixed with B cells from either C57BL/6 or C3H/OuJ mice. Results ( Table   Table 7 The effector cell populations tested in these assays are heterogeneous, which makes it difficult to know precisely which cells are responsible for the observed effects. To analyze this question cell populations were treated with antibody and C to eliminate cells expressing NK1 and CD3. * Cells were cultured for 2 d in the presence of LPS. * C57BL/6 lpr mice (also analyzed in Pig. 5, E and F) were injected with cells from C57BL/6 nude spleen. NK1 + cells were enriched from nude spleen by removing B cells by panning, resulting in 30-40% NK1 + CD3 + and 20-30% NK1 + CD3-cells. Cells (5 x 106 per mouse) were injected intravenously at the age of 7, 9, and 13 wk.
C57BL/6 Ipr B ceils is decreased by treatment with anti CD3 + C from 46--48% to 19-24%, but that there is no effect of antibody treatment on suppression of C3H gld B cells Continued injection of this antibody leads to complete elimination of NK1 + cells (9, and data not shown). Assay of splenic B cells from injected or control mice for anti-DNA antibody-secreting cells revealed a small but significant increase at 6 wk. This increase was more pronounced at later time points, when antibody-treated mice had 50% more cells producing autoantibody (Table 6 ). Assay of antibody-injected or control Ipr mice by fluorometry for cells expressing B220 and CD3 revealed no significant differences (data not shown). These results show that removal ofcens expressing NK1 stimulates the appearance of autoantibody-secreting B cells in lpr mice but has no demonstrable effect on the appearance of B220 + CD3 + cells.
Since removal of NK1 + cells in vivo causes accelerated development of autoimmunity, one might expect that adoptive transfer of cell populations enriched for NK1 + cells into lpr mice should delay its development. To examine this prediction NK1 + cells were enriched from C57BL/6 nu spleen cells by depleting spleen cells of B cells (3) . The resulting population typically consists of 30-40% NK1 + CD3 + cells and 20-30% NK1 + CD3-cells (3) . This cell population was adoptively transferred into C57BL/6 lpr mice at the age of 7 and 9 wk. At 12 wk animals were killed and tested for autoantibody-secreting B cells. Results in Table 7 (Table 7) , whereas again mice that received adoptive cell transfers have much lower numbers of autoantibody-secreting ceils (Table 7) . However, the number of autoantibody-secreting B cells is significantly higher than that of normal mice or young lpr mice, which shows that adoptive cell transfers cause a significant delay in appearance but not a complete suppression of autoimmunity.
As 
Discussion
The ability of lethally irradiated Ft hybrid mice to acutely reject parental marrow grafts has been somewhat of an enigma in transplantation immunology. A long-standing explanation for this phenomenon has been that hemopoietic histocompatibility (Hh) antigens are responsible for the rejection and that expression of these antigens requires homozygosity (21) . While presently it is not known with certainty whether Hh antigens indeed exist, an alternative possibility is that the rejection mechanism responsible involves effector cells that recognize self-antigens. In support of this, we had previously shown that removal of NK1 + cells from normal mice by various means may lead to failure to control proliferation of endogenous CFU-S in lightly irradiated animals (5). In keeping with this observation, we show here that in young mice up to the age of 3 wk the abilities to reject allogeneic marrow and to control endogenous CFU-S proliferation are not demonstrable and that both functions appear at a time when NK1 + cells are demonstrable. (F) C57BL/6 Ipr, 16 wk old, had been injected with the same call populations and dose as in E at the age of 7, 9, and 13 wk.
In normal mice the ability to reject marrow grafts and to control endogenous marrow stem cells persists, whereas in mice homozygous for the Ipr gene these functions disappear concomitant with a loss of NK1 + cells. This pointed to the possibility that NK1 + cells play a role not only in controlling marrow stem cell proliferation but also in downmodulating immune functions. In attempts to gather support for this, young Ipr mice were treated with antibody to remove NK1 + cells. This resulted in a significant increase in autoantibody-secreting B cells. The reverse was accomplished by injection of cell populations enriched for NK1 + cells. There was suppression to normal levels of the number of autoantibody-secreting B cells consistent with the interpretation that these cells have downregulatory effects on B cells. An interesting observation is that injection of cell populations enriched for NK1 + cells into lpr mice causes complete suppression of B220 + CD3 + cells responsible for lymphadenopathy at the later stages of the disease. This could indicate that NK1 + cells have immunosurveillance functions and control the proliferation of B220 + CD3 + cells. The obser-cation that treatment of Ipr mice with anti-NK1 has no demonstrable effect on B220 + CD3 + ceUs has to be interpreted in view of the fact that NK1 + cells develop from NK1-precursors (3, 22) . Therefore, injection of anti-NK1 will not remove precursors of NK1 + cells but may suffice to cause effects on autoantibody-secreting B cells.
A very interesting question is precisely which subpopulation of NK1 + cells is responsible for the observed effects. It is a well-established observation that NK1 + cells have homeostatic effects on antibody responses (23) , but the relative contributions of NK1 + CD3-and NK1 + CD3 + cells have not been elucidated. Our in vitro experiments provide clues to answer this question. We show that suppression of C3H B ceils by BCF1 calls is due to NK1 + CD3-cells, whereas suppression of C57BL/6 B cells is due to NK1 § CD3 + effector cells. This is consistent with the interpretation that NK1 + CD3-cells have nonspecific, whereas NK1 + CD3 + cells have specific, suppressive effects. One could speculate from this that the specific suppressive effects demonstrable with NK1 § CD3 + cells are a reflection of the in vivo phenomenon of hybrid resistance. This is strongly supported by the previous demonstration that NK1 + CD3 + cells are responsible for acute parental marrow graft rejection in BCF1 mice (1) . The finding that NK1 + CD3 + cells have specific effects is most likely explained by the expression of TCKs. Recent experiments have shown that NK1 + CD3 § cells possess TCR o~//3 chains and that a change in one of the chains interferes with the function of these cells. Thus, in C57BL/6 mice expressing the TCK V/35 transgene, NK1 + CD3 + cells are present but specific acute marrow graft rejection is not demonstrable (24) . The absence of TCRs on NK1 § CD3-cells is consistent with their nonspecific suppressive effect although this does not exclude that they express specificities yet to be uncovered. The observation that SCID mice that possess NK1 + CD3-but not NK1 + CD3 + cells reject marrow grafts may point to this possibility (4) .
Both NK1 + CD3-as well as NK1 + CD3 + cells show suppressive effects in our in vitro assays. It therefore is likely that both cell types act synergistically in vivo. It is difficult to design experiments to assess the relative contributions of either cell type in the development of autoimmunity. The reason for this is that both cells develop from NK1-CD3-precursors (1, 3, 22) and in normal mice they are not readily demonstrable by FACS | staining (1, 3) because they express low amounts of antigen. Culture of cells for 2-5 d in Ib2 causes stimulation of antigen expression, which makes possible identification of both phenotypes by double staining (1, 3, 22) . Despite this, purification of phenotypically stable cell populations from IL-2-cultured ceils turned out to be impossible because of antigen modulation (our unpublished results). Therefore, isolation of homogeneous cell populations for in vivo adoptive cell transfer experiments is not feasible.
Our finding that NK1 § cells have a downregulatory function on the proliferation of bone marrow stem cells is in agreement with a previous result by Hansson et al. (25) . These authors reported that depletion of NK1 + cells in normal mice by continued injection of anti-NK1 antibody results in
